Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating Activities:
Net income (loss)	$ 45,805	$ 62,195
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	28,083	25,732
Consumer loan loss provision	26,335	19,982
Deferred income taxes	(1,280)	245
Other adjustments	4,252	73
(Gain) loss on sale or disposal of assets	(6,137)	6,060
Gain on sale of loan portfolio	(14,312)	0
Stock compensation	9,929	5,202
Income from investments in unconsolidated affiliates	(3,880)	(13,491)
Impairment of investments	7,940	0
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable, net	(4,407)	(4,203)
Inventory, net	1,061	(51)
Prepaid expenses, other current assets, and other assets, net	(25,402)	(13,119)
Accounts payable and accrued expenses	(7,221)	7,330
Customer layaway deposits	(433)	588
Deferred gains and other long-term liabilities	943	439
Tax provision (benefit) from stock compensation	570	(321)
Prepaid income taxes	(6,196)	(5,664)
Dividends from unconsolidated affiliates	5,129	8,418
Net cash provided by operating activities	60,779	99,415
Investing Activities:
Loans made	(705,181)	(682,184)
Loans repaid	476,196	451,182
Recovery of pawn loan principal through sale of forfeited collateral	182,004	181,461
Additions to property and equipment	(15,930)	(33,351)
Acquisitions, net of cash acquired	(12,990)	(14,940)
Investments in unconsolidated affiliates	0	(11,018)
Proceeds from sale of assets	44,568	0
Other investing activities	143	0
Net cash used in investing activities	(31,190)	(108,850)
Financing Activities:
Proceeds from exercise of stock options	0	45
Tax provision (benefit) from stock compensation	(569)	321
Taxes paid related to net share settlement of equity awards	(1,990)	(3,596)
Debt issuance costs	(12,686)	0
Payout of deferred and contingent consideration	(23,000)	0
Proceeds from issuance of convertible notes	200,000	0
Purchase of convertible notes hedges	(40,395)	0
Proceeds from issuance of warrants	21,824	0
Purchase of subsidiary shares from noncontrolling interest	(21,139)	0
Change in restricted cash	(29,992)	96
Proceeds from revolving line of credit	389,900	403,131
Payments on revolving line of credit	(530,800)	(385,964)
Proceeds from bank borrowings	102,138	21,637
Payments on bank borrowings and capital lease obligations	(57,578)	(28,001)
Repurchase of common stock	(11,901)	0
Net cash (used in) provided by financing activities	(16,188)	7,669
Effect of exchange rate changes on cash and cash equivalents	281	(756)
Net increase (decrease) in cash and cash equivalents	13,682	(2,522)
Cash and cash equivalents at beginning of period	36,317	48,477
Cash and cash equivalents at end of period	49,999	45,955
Non-cash Investing and Financing Activities:
Pawn loans forfeited and transferred to inventory	171,288	192,150
Issuance of common stock due to acquisitions	0	38,705
Deferred consideration	2,692	25,872
Contingent consideration	0	7,148
Accrued additions to property and equipment	0	107
Issuance of common stock to 401(k) plan	557	0
Equity adjustment due to noncontrolling interest purchase	6,588	0
Receivable from sale of portfolio	38,269	0
Receivable from issuance of convertible notes	30,000	0
Payable to purchase convertible note hedges	6,059	0
Warrants receivable related to issuance of convertible notes	3,282	0
Deferred finance cost payable related to convertible notes	2,400	0
Payable to purchase additional shares of noncontrolling interest	$ 8,636	$ 0